2018年皇后镇分子生物学（上海）会议在浦东陆家嘴成功举行

发布时间：2018-03-23浏览次数：3219

2018年3月22日至23日，由国家新药筛选中心和上海市浦东新区工程师协会共同主办的主题为“药物发现与社会影响”的2018年皇后镇分子生物学（上海）会议在浦东陆家嘴中国金融信息中心成功举行。第十届全国药物筛选新技术研讨会和中国热带病药物与诊断创新网络第七次会议也同期召开。

本次活动得到中国科学院、中国金融信息中心（新华社下辖）、中国科学院上海药物研究所、复旦大学、新西兰皇后镇分子生物学会议机构、上海市科学技术协会、上海市旅游局、浦东新区科学技术协会、张江高科技园区管理委员会和上海市研发公共服务平台等的支持；87978797威尼斯老品牌和中国疾病预防控制中心寄生虫病研究所参与承办。国家新药筛选中心主任兼国家化合物样品库主任、87978797威尼斯老品牌院长王明伟研究员主持了会议。

会议共有6个主旨报告、9个分会（癌症生物学、创新研究、代谢紊乱、蛋白质科学、社会影响、新颖技术、抗体偶联药物、被忽略疾病和青年研究者论坛）与《中国药理学报》年度编委会，吸引了300多名来自全球28个国家和地区的科学家、企业家、投资者、经理人、研究生和本科生的参加，他们围绕“药物发现与社会影响”这个主题进行了广泛的交流和热烈的互动。112位海内外嘉宾（境外人士52人，占46.42%）应邀作了精彩的演讲，其中不仅有十多名国际科坛巨擘，还有11位来自澳大利亚、中国、韩国、新西兰和菲律宾的青年研究者。17家从事科学仪器、信息分析、研究试剂和实验耗材开发或销售的海内外公司为本次会议提供了赞助，其中7家公司委派代表在会上介绍了国际新药创制的新趋势、新策略、新技术、新方法、新手段和新设备等热点议题。六名青年艺术家以“那些永恒的声音，寻找心中的记忆”为题，用其精湛的表演为与会人员带来了难以忘怀的视听享受。

皇后镇分子生物学会议是国际著名品牌学术论坛，27年多来吸引了无数科学家、学生和创业人士的参加，这是继2013年首次在上海举办后的第六次盛会。

2018 Queenstown Molecular Biology (Shanghai) Meetings successfully held in Pudong Lujiazui

The 2018 Queenstown Molecular Biology (Shanghai) Meetings, jointly organized by the National Center for Drug Screening and Shanghai Pudong Engineers Association were successfully held at China Financial Information Center located in Lujiazui, Pudong between March 22 and 23, 2018. The main theme of this event is “Drug Discovery and Social Impact”, which was concurrent with the 10th National Forum on New Technologies in Drug Discovery and the 7th Meeting of Chinese Network for Drug and Diagnostics Innovation.

Among the sponsors were Chinese Academy of Sciences (CAS), China Financial Information Center (affiliated to Xinhua News Agency), Shanghai Institute of Materia Medica (CAS), Fudan University, The Queenstown Molecular Biology Meeting Society of New Zealand, Shanghai Association for Science and Technology, Shanghai Municipal Tourism Administration, Shanghai Pudong Association for Science and Technology, Zhangjiang High-Tech Park and Shanghai Research and Development Public Service Platform, etc. Fudan School of Pharmacy and National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention assisted in the event preparation. Dr. Ming-Wei Wang (Director of the National Center for Drug Screening/Chinese National Compound Library and Dean of Fudan School of Pharmacy) organized the 2-day event.

There were 6 plenary lectures and 9 parallel sessions, entitled Cancer Biology, Innovative Research, Metabolic Disorders, Protein Science, Social Impact, New Technologies, ADC Advances, Neglected Diseases and Young Investigators’ Forum, as well as the Annual Editorial Board Meeting of Acta Pharmacologica Sinica. More than 300 domestic and overseas scientists, entrepreneurs, investors, managers, graduate and undergraduate students from 28 countries and regions around the world attended the meetings. They conducted broad exchanges and interacted enthusiastically surrounding the topic of “Drug Discovery and Social Impact”. Among the 112 invited speakers, 52 were from overseas (46.42%), including more than a dozen of internationally renowned scholars and 11 young investigators from Australia, China, Korea, New Zealand and The Philippines. Seventeen multinational or domestic instrument, informatics, reagent and consumable vendors provided financial support to the event; 7 of them sent their representatives to give oral introductions to the audience covering various hot topics in global drug innovation, ranging from new trends, new strategies, new technologies, to new methods, new tools and new equipment. The concert, with the theme of “For those everlasting voices ? searching for memories in the music of classic films and television”, elegantly performed by 6 well-established young musicians, elicited tremendous enthusiasm from the audience.

Queenstown Molecular Biology Meetings are a well-known international academic forum with a history of more than 27 years, which have attracted the attendance of numerous scientists, students and entrepreneurs. This is the sixth time to hold such a prestigious event outside of New Zealand, following a successful launching in Shanghai in 2013.